Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OCTREOTIDE Cause Complication associated with device? 14 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Complication associated with device have been filed in association with OCTREOTIDE (Octreotide Acetate). This represents 0.1% of all adverse event reports for OCTREOTIDE.

14
Reports of Complication associated with device with OCTREOTIDE
0.1%
of all OCTREOTIDE reports
3
Deaths
10
Hospitalizations

How Dangerous Is Complication associated with device From OCTREOTIDE?

Of the 14 reports, 3 (21.4%) resulted in death, 10 (71.4%) required hospitalization.

Is Complication associated with device Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OCTREOTIDE. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does OCTREOTIDE Cause?

Death (3,801) Diarrhoea (3,621) Fatigue (2,933) Blood pressure increased (2,799) Needle issue (2,740) Malaise (2,737) Pain (2,366) Blood pressure systolic increased (2,340) Malignant neoplasm progression (2,306) Nausea (2,294)

What Other Drugs Cause Complication associated with device?

ETONOGESTREL (6,047) COPPER (1,083) BACLOFEN (525) TREPROSTINIL (422) EPOPROSTENOL (399) LEVONORGESTREL (344) ADALIMUMAB (269) CARBIDOPA\LEVODOPA (169) MACITENTAN (169) TEDUGLUTIDE (133)

Which OCTREOTIDE Alternatives Have Lower Complication associated with device Risk?

OCTREOTIDE vs OCTREOTIDE\OCTREOTIDE OCTREOTIDE vs ODEVIXIBAT OCTREOTIDE vs OFATUMUMAB OCTREOTIDE vs OFLOXACIN OCTREOTIDE vs OLANZAPINE

Related Pages

OCTREOTIDE Full Profile All Complication associated with device Reports All Drugs Causing Complication associated with device OCTREOTIDE Demographics